United States· US:0078-0249_f052c25a-d848-4b2d-8ff3-73bee0c89ad7
Femara
A medicinal product containing letrozole, registered in United States by Novartis Pharmaceuticals Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- letrozole
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11007802491530 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0078-0249-15)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Letrozole in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALETROPHARMAGEN CZ s.r.o., Praha
- SpainFEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Farmaceutica S.A.
- ItalyBRESTORALWAVE PHARMA S.R.L.
- SwitzerlandFemara
- FranceFEMARA 2,5 mg, comprimé pelliculéBB FARMA (ITALIE)
- FinlandFemarNovartis Finland Oy
- NetherlandsEtruzil 2,5 mg, filmomhulde tablettenEgis Pharmaceuticals
- BelgiumFemara 2.5 mgPI Pharma
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Femara, Letrofam
- Belgium · Femara, Letrozol Sandoz
- Bulgaria · Етрузил, Зеквипра
- Cyprus · Femara, Feremazol
- Czechia · Aletro, Dracenax
- Germany · Femara, Letro-Cell
- Denmark · Letrozol Accord, Letrozol Medical Valley
- Estonia · Femara, Feremazol
- Spain · Femara, Galdar
- Finland · Femar, Letrolan
- France · Femara, Letrozole Accord Healthcare
- United Kingdom (Northern Ireland) · Femara, Letrozole
- Greece · Femaplex, Femara
- Croatia · Avomit, Femara
- Hungary · Etruzil, Famos
- Ireland · Femara, Letrozole Accord Healthcare Ireland
- Iceland · Letromal, Letrozol Actavis
- Italy · Blormat, Brestoral
- Lithuania · Femara, Feremazol
- Luxembourg · Femara, Letrozole Eg
- Latvia · Femara, Letrozole Sanoswiss
- Malta · Femara, Feremazol
- Netherlands · Etruzil, Letrostar
- Norway · Femar, Letrozol Accord
- Poland · Aromek, Clarzole
- Portugal · Femara, Letrozol Accord
- Romania · Elozora, Etruzil
- Sweden · Letrozol Accord, Letrozol Medical Valley
- Slovenia · Femara, Letrozol Genthon
- Slovakia · Aletro, Etruzil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9cfcb4c3-43ff-421e-83df-eb63959f1490 GET /v1/drugs/9cfcb4c3-43ff-421e-83df-eb63959f1490?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"productid": "0078-0249_f052c25a-d848-4b2d-8ff3-73bee0c89ad7",
"productndc": "0078-0249",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LETROZOLE",
"proprietary_name": "Femara",
"active_ingred_unit": "mg/1",
"application_number": "NDA020726",
"marketing_category": "NDA",
"nonproprietary_name": "letrozole",
"start_marketing_date": "19970731",
"active_numerator_strength": "2.5"
}See everything about letrozole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.